Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating activities
Net (loss) income	$ (9,403)	$ 822,011
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	455,554	176,077
Amortization of deferred financing costs and debt discount	8,096	9,219
Straight-line rent revenue and other	(116,466)	(145,725)
Stock / (Unit)-based compensation expense	18,266	21,912
Gain on sale of real estate	(229)	(467,993)
Real estate and other impairment charges	89,538	4,875
Straight-line rent and other write-off	97,834	(328)
Debt refinancing and unutilized financing costs	816	9,435
Tax rate changes and other	(164,535)	(825)
Non-cash revenue from debt and equity securities received	(68,557)
Other adjustments	(8,296)	(13,170)
Changes in:
Interest and rent receivables	(62,132)	(44,224)
Other assets	(9,514)	(6,343)
Accounts payable and accrued expenses	(25,609)	(15,558)
Deferred revenue	6,814	(5,347)
Net cash provided by operating activities	212,177	344,016
Investing activities
Cash paid for acquisitions and other related investments	(235,187)	(946,243)
Net proceeds from sale of real estate	489,420	1,817,642
Principal received on loans receivable	389,385	19,478
Investment in loans receivable	(55,223)	(175,734)
Construction in progress and other	(28,639)	(91,167)
Proceeds from return of equity investments		775
Capital additions and other investments, net	(150,757)	(90,623)
Net cash provided by investing activities	408,999	534,128
Financing activities
Payments of term debt	(485,523)	(869,606)
Revolving credit facility, net	270,863	200,945
Dividends paid	(350,304)	(350,519)
Lease deposits and other obligations to tenants	7,154	3,174
Stock vesting - satisfaction of tax withholdings	(5,570)	(28,799)
Debt refinancing, deferred financing costs, and other financing activities	12,439	(17,917)
Net cash used for financing activities	(550,941)	(1,062,722)
Increase (decrease) in cash, cash equivalents, and restricted cash for period	70,235	(184,578)
Effect of exchange rate changes	18,184	(14,786)
Cash, cash equivalents, and restricted cash at beginning of period	241,538	461,882
Cash, cash equivalents, and restricted cash at end of period	329,957	262,518
Interest paid	227,361	209,445
Supplemental schedule of non-cash investing activities:
Debt and equity securities received for certain obligations, real estate, and revenue	804,520
Certain obligations and receivables satisfied and real estate sold	735,963
Supplemental schedule of non-cash financing activities:
Dividends declared, unpaid	173,851	174,017
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	235,668	459,227
Restricted cash, included in Other assets at beginning of period	$ 5,870	$ 2,655
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at beginning of period	$ 241,538	$ 461,882
Cash and cash equivalents at end of period	324,050	257,269
Restricted cash, included in Other assets at end of period	$ 5,907	$ 5,249
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at end of period	$ 329,957	$ 262,518
MPT Operating Partnership, L.P. [Member]
Operating activities
Net (loss) income	(9,403)	822,011
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	455,554	176,077
Amortization of deferred financing costs and debt discount	8,096	9,219
Straight-line rent revenue and other	(116,466)	(145,725)
Stock / (Unit)-based compensation expense	18,266	21,912
Gain on sale of real estate	(229)	(467,993)
Real estate and other impairment charges	89,538	4,875
Straight-line rent and other write-off	97,834	(328)
Debt refinancing and unutilized financing costs	816	9,435
Tax rate changes and other	(164,535)	(825)
Non-cash revenue from debt and equity securities received	(68,557)
Other adjustments	(8,296)	(13,170)
Changes in:
Interest and rent receivables	(62,132)	(44,224)
Other assets	(9,514)	(6,343)
Accounts payable and accrued expenses	(25,609)	(15,558)
Deferred revenue	6,814	(5,347)
Net cash provided by operating activities	212,177	344,016
Investing activities
Cash paid for acquisitions and other related investments	(235,187)	(946,243)
Net proceeds from sale of real estate	489,420	1,817,642
Principal received on loans receivable	389,385	19,478
Investment in loans receivable	(55,223)	(175,734)
Construction in progress and other	(28,639)	(91,167)
Proceeds from return of equity investments		775
Capital additions and other investments, net	(150,757)	(90,623)
Net cash provided by investing activities	408,999	534,128
Financing activities
Payments of term debt	(485,523)	(869,606)
Revolving credit facility, net	270,863	200,945
Dividends paid	(350,304)	(350,519)
Lease deposits and other obligations to tenants	7,154	3,174
Stock vesting - satisfaction of tax withholdings	(5,570)	(28,799)
Debt refinancing, deferred financing costs, and other financing activities	12,439	(17,917)
Net cash used for financing activities	(550,941)	(1,062,722)
Increase (decrease) in cash, cash equivalents, and restricted cash for period	70,235	(184,578)
Effect of exchange rate changes	18,184	(14,786)
Cash, cash equivalents, and restricted cash at beginning of period	241,538	461,882
Cash, cash equivalents, and restricted cash at end of period	329,957	262,518
Interest paid	227,361	209,445
Supplemental schedule of non-cash investing activities:
Debt and equity securities received for certain obligations, real estate, and revenue	804,520
Certain obligations and receivables satisfied and real estate sold	735,963
Supplemental schedule of non-cash financing activities:
Dividends declared, unpaid	173,851	174,017
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	235,668	459,227
Restricted cash, included in Other assets at beginning of period	$ 5,870	$ 2,655
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at beginning of period	$ 241,538	$ 461,882
Cash and cash equivalents at end of period	324,050	257,269
Restricted cash, included in Other assets at end of period	$ 5,907	$ 5,249
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at end of period	$ 329,957	$ 262,518